Alzheimer's disease (AD) is a heterogeneous progressive neurocognitive disorder. Although
different neuroimaging modalities have been used for the identification of early diagnostic …

Background Type 2 diabetes mellitus (T2DM) is known to be associated with cognitive
decline and brain structural changes. This study systematically reviews and estimates …

Mild cognitive impairment (MCI) is an intermediary stage condition between healthy people
and Alzheimer's disease (AD) patients and other dementias. AD is a progressive and …

Functional connectivity (FC) alterations represent a key feature in Alzheimer's Disease (AD)
and provide a useful tool to characterize and predict the course of the disease. Those …

Retrograded starch is known to be resistant to digestion. We used enzyme kinetic
experiments to examine how retrogradation of starch affects amylolysis catalysed by porcine …

Background For the recruitment and monitoring of subjects for therapy studies, it is important
to predict whether mild cognitive impaired (MCI) subjects will prospectively develop …

Background and Objectives We assessed whether novelty-related fMRI activity in medial
temporal lobe regions and the precuneus follows an inverted U-shaped pattern across the …

Individuals with intact cognition and neuropathology consistent with Alzheimer's disease
(AD) are referred to as asymptomatic AD (AsymAD). These individuals are highly likely to …

Retinal assessments have been discussed as biomarkers for brain atrophy. However,
available studies did not investigate all retinal layers due to older technology, reported …

Background There is evidence that both omega-3 long-chain polyunsaturated fatty acids
(PUFAs)(eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) and cocoa …